These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 33099839)

  • 1. Analysis of 11 candidate genes in 849 adult patients with suspected hereditary cancer predisposition.
    Cavaillé M; Uhrhammer N; Privat M; Ponelle-Chachuat F; Gay-Bellile M; Lepage M; Molnar I; Viala S; Bidet Y; Bignon YJ
    Genes Chromosomes Cancer; 2021 Feb; 60(2):73-78. PubMed ID: 33099839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Germline mutation in the RAD51B gene confers predisposition to breast cancer.
    Golmard L; Caux-Moncoutier V; Davy G; Al Ageeli E; Poirot B; Tirapo C; Michaux D; Barbaroux C; d'Enghien CD; Nicolas A; Castéra L; Sastre-Garau X; Stern MH; Houdayer C; Stoppa-Lyonnet D
    BMC Cancer; 2013 Oct; 13():484. PubMed ID: 24139550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reevaluation of RINT1 as a breast cancer predisposition gene.
    Li N; Thompson ER; Rowley SM; McInerny S; Devereux L; Goode D; ; Wong-Brown MW; Scott RJ; Trainer AH; Gorringe KL; James PA; Campbell IG
    Breast Cancer Res Treat; 2016 Sep; 159(2):385-92. PubMed ID: 27544226
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Rofes P; Del Valle J; Torres-Esquius S; Feliubadaló L; Stradella A; Moreno-Cabrera JM; López-Doriga A; Munté E; De Cid R; Campos O; Cuesta R; Teulé Á; Grau È; Sanz J; Capellá G; Díez O; Brunet J; Balmaña J; Lázaro C
    Genes (Basel); 2021 Jan; 12(2):. PubMed ID: 33498765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Rare Pathogenic DNA Variants for Familial Hypercholesterolemia, Hereditary Breast and Ovarian Cancer Syndrome, and Lynch Syndrome With Disease Risk in Adults According to Family History.
    Patel AP; Wang M; Fahed AC; Mason-Suares H; Brockman D; Pelletier R; Amr S; Machini K; Hawley M; Witkowski L; Koch C; Philippakis A; Cassa CA; Ellinor PT; Kathiresan S; Ng K; Lebo M; Khera AV
    JAMA Netw Open; 2020 Apr; 3(4):e203959. PubMed ID: 32347951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multigene panel testing beyond BRCA1/2 in breast/ovarian cancer Spanish families and clinical actionability of findings.
    Bonache S; Esteban I; Moles-Fernández A; Tenés A; Duran-Lozano L; Montalban G; Bach V; Carrasco E; Gadea N; López-Fernández A; Torres-Esquius S; Mancuso F; Caratú G; Vivancos A; Tuset N; Balmaña J; Gutiérrez-Enríquez S; Diez O
    J Cancer Res Clin Oncol; 2018 Dec; 144(12):2495-2513. PubMed ID: 30306255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of mutations in BRCA and MMR genes in patients affected with hereditary endometrial cancer.
    Vietri MT; D'Elia G; Caliendo G; Casamassimi A; Federico A; Passariello L; Cioffi M; Molinari AM
    Med Oncol; 2021 Jan; 38(2):13. PubMed ID: 33484353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rare mutations in RINT1 predispose carriers to breast and Lynch syndrome-spectrum cancers.
    Park DJ; Tao K; Le Calvez-Kelm F; Nguyen-Dumont T; Robinot N; Hammet F; Odefrey F; Tsimiklis H; Teo ZL; Thingholm LB; Young EL; Voegele C; Lonie A; Pope BJ; Roane TC; Bell R; Hu H; Shankaracharya ; Huff CD; Ellis J; Li J; Makunin IV; John EM; Andrulis IL; Terry MB; Daly M; Buys SS; Snyder C; Lynch HT; Devilee P; Giles GG; Hopper JL; Feng BJ; Lesueur F; Tavtigian SV; Southey MC; Goldgar DE
    Cancer Discov; 2014 Jul; 4(7):804-15. PubMed ID: 25050558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prioritizing Variants in Complete Hereditary Breast and Ovarian Cancer Genes in Patients Lacking Known BRCA Mutations.
    Caminsky NG; Mucaki EJ; Perri AM; Lu R; Knoll JH; Rogan PK
    Hum Mutat; 2016 Jul; 37(7):640-52. PubMed ID: 26898890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Whole-exome sequencing identifies rare pathogenic variants in new predisposition genes for familial colorectal cancer.
    Esteban-Jurado C; Vila-Casadesús M; Garre P; Lozano JJ; Pristoupilova A; Beltran S; Muñoz J; Ocaña T; Balaguer F; López-Cerón M; Cuatrecasas M; Franch-Expósito S; Piqué JM; Castells A; Carracedo A; Ruiz-Ponte C; Abulí A; Bessa X; Andreu M; Bujanda L; Caldés T; Castellví-Bel S
    Genet Med; 2015 Feb; 17(2):131-42. PubMed ID: 25058500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted RNA-seq successfully identifies normal and pathogenic splicing events in breast/ovarian cancer susceptibility and Lynch syndrome genes.
    Brandão RD; Mensaert K; López-Perolio I; Tserpelis D; Xenakis M; Lattimore V; Walker LC; Kvist A; Vega A; Gutiérrez-Enríquez S; Díez O; ; de la Hoya M; Spurdle AB; De Meyer T; Blok MJ
    Int J Cancer; 2019 Jul; 145(2):401-414. PubMed ID: 30623411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update on genetic predisposition to colorectal cancer and polyposis.
    Valle L; de Voer RM; Goldberg Y; Sjursen W; Försti A; Ruiz-Ponte C; Caldés T; Garré P; Olsen MF; Nordling M; Castellvi-Bel S; Hemminki K
    Mol Aspects Med; 2019 Oct; 69():10-26. PubMed ID: 30862463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigating barriers to genetic counseling and germline mutation testing in women with suspected hereditary breast and ovarian cancer syndrome and Lynch syndrome.
    Shaw J; Bulsara C; Cohen PA; Gryta M; Nichols CB; Schofield L; O'Sullivan S; Pachter N; Hardcastle SJ
    Patient Educ Couns; 2018 May; 101(5):938-944. PubMed ID: 29273311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Managing families with a hereditary cancer syndrome.
    Mahon SM
    Oncol Nurs Forum; 2011 Nov; 38(6):641-4. PubMed ID: 22037327
    [No Abstract]   [Full Text] [Related]  

  • 15. Targeted massively parallel sequencing of a panel of putative breast cancer susceptibility genes in a large cohort of multiple-case breast and ovarian cancer families.
    Li J; Meeks H; Feng BJ; Healey S; Thorne H; Makunin I; Ellis J; ; Campbell I; Southey M; Mitchell G; Clouston D; Kirk J; Goldgar D; Chenevix-Trench G
    J Med Genet; 2016 Jan; 53(1):34-42. PubMed ID: 26534844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RAD51C germline mutations in breast and ovarian cancer cases from high-risk families.
    Clague J; Wilhoite G; Adamson A; Bailis A; Weitzel JN; Neuhausen SL
    PLoS One; 2011; 6(9):e25632. PubMed ID: 21980511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of Germline Variants in 450 Breast/Ovarian Cancer Families with a Multi-Gene Panel Including Coding and Regulatory Regions.
    Guglielmi C; Scarpitta R; Gambino G; Conti E; Bellè F; Tancredi M; Cervelli T; Falaschi E; Cosini C; Aretini P; Congregati C; Marino M; Patruno M; Pilato B; Spina F; Balestrino L; Tenedini E; Carnevali I; Cortesi L; Tagliafico E; Tibiletti MG; Tommasi S; Ghilli M; Vivanet C; Galli A; Caligo MA
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ovarian Cancer in Hereditary Cancer Susceptibility Syndromes.
    Nakonechny QB; Gilks CB
    Surg Pathol Clin; 2016 Jun; 9(2):189-99. PubMed ID: 27241103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identifying sequence variants contributing to hereditary breast and ovarian cancer in BRCA1 and BRCA2 negative breast and ovarian cancer patients.
    Jarhelle E; Riise Stensland HMF; Hansen GÅM; Skarsfjord S; Jonsrud C; Ingebrigtsen M; Strømsvik N; Van Ghelue M
    Sci Rep; 2019 Dec; 9(1):19986. PubMed ID: 31882575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Features and Clinical Management of Hereditary Gynecological Cancers.
    Ueki A; Hirasawa A
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33327492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.